8-K: PEDEVCO Corp. Restates 2024 Financials Due to Tax Error

PEDEVCO Corp. announced that its 2024 financial statements can no longer be relied upon and will be restated due to a $5.5 million tax accounting error.

Summary

• The Audit Committee of PEDEVCO Corp.'s Board of Directors concluded on October 27, 2025, that the company's previously issued audited financial statements for the fiscal year ended December 31, 2024, should no longer be relied upon and require restatement.
• The restatement is due to an error in accounting for prior period net operating losses in the calculation of the tax provision, which resulted in an overstatement of the company's tax benefit and deferred income tax account.
• This error led to an overstatement of approximately $5.5 million in the company's tax benefit and deferred income tax account for the fiscal year ended December 31, 2024.
• The error did not have any impact on the company's cash position, cash flow, revenues, or liquidity.
• The correction of the error will result in a decrease of approximately $5.5 million in net income, income tax benefit, total assets, total shareholders' equity, and total liabilities and shareholders' equity for December 31, 2024.
• Earnings per basic and diluted common share for the fiscal year ended December 31, 2024, will decrease from $0.20 to $0.14.
• Management has identified additional material weaknesses in the company's internal control over financial reporting and disclosure controls and procedures as of December 31, 2024.
• The company is currently working to complete the filing of its amended Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which will include the restated consolidated financial statements.

Sentiment

Score: 3

Explanation: The filing indicates significant negative news, including a financial restatement, a material reduction in reported earnings, and the identification of material weaknesses in internal controls, all of which typically lead to a negative market reaction and increased investor uncertainty.

Negatives

• Previously issued audited financial statements for fiscal year 2024 can no longer be relied upon and require restatement.
• A $5.5 million overstatement of the tax benefit and deferred income tax account for fiscal year 2024.
• Net income, income tax benefit, total assets, total shareholders' equity, and total liabilities and shareholders' equity for December 31, 2024, will decrease by approximately $5.5 million.
• Earnings per basic and diluted common share for fiscal year 2024 will decrease from $0.20 to $0.14.
• Identification of additional material weaknesses in internal control over financial reporting and disclosure controls and procedures as of December 31, 2024.

Risks

• The timing and nature of the resolution of the accounting issues discussed in this report.
• Any potential delay in the filing of required periodic reports, specifically the amended Annual Report on Form 10-K.
• The possibility that a restatement of financial results will be required for other accounting issues not yet identified.
• Adverse effects on the company's business related to the disclosures made in this report.
• Volatility of the company's stock price due to these events.

Future Outlook

The company is working to complete the filing of its amended Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which will include restated consolidated financial statements. Management is also in the process of creating a plan of remediation to address the identified material weaknesses in internal control over financial reporting.

Management Comments

• Management has identified additional material weaknesses in the company's internal control over financial reporting and disclosure controls and procedures as of December 31, 2024.
• Management is in the process of creating a plan of remediation to address the material weakness.
• The company is working to complete the filing of its amended Annual Report Form 10-K for the fiscal year ended December 31, 2024.

Industry Context

This announcement primarily concerns a company-specific accounting error and internal control deficiencies, rather than broader industry trends. However, financial restatements and material weaknesses in internal controls can erode investor confidence and potentially lead to increased scrutiny from regulators and auditors across the industry, emphasizing the importance of robust financial reporting practices.

Corporate Governance

Stakeholder Impact

• Shareholders/Investors: Will experience a reduction in reported earnings per share for 2024, potential stock price volatility, and increased uncertainty regarding the reliability of past financial reporting.
• Management: Responsible for addressing the material weaknesses in internal controls and ensuring accurate future financial reporting.
• Auditors (Marcum LLP and Weaver and Tidwell, L.L.P.): Involved in the discussions regarding the non-reliance and restatement, highlighting their role in financial oversight and the implications for audit reports.
• Regulatory Authorities (SEC): Will review the amended Form 10-K and the company's remediation efforts regarding internal controls.

Next Steps

• Complete the filing of the amended Annual Report on Form 10-K for the fiscal year ended December 31, 2024, including restated consolidated financial statements.
• Develop and implement a plan of remediation to address the identified material weaknesses in internal control over financial reporting and disclosure controls and procedures.

Key Dates

Recommendation

The restatement of previously issued financial statements, a significant reduction in reported earnings per share, and the identification of material weaknesses in internal controls are all strong negative indicators. These issues create substantial uncertainty regarding the company's financial health and operational integrity, likely leading to a negative market reaction and warranting a 'sell' recommendation until these issues are fully resolved and confidence in financial reporting is restored.

Keywords

PEDEVCO, Financial Restatement, Accounting Error, Tax Provision, Net Operating Losses, Internal Controls, Material Weakness, Form 8-K, Form 10-K, SEC Filing, Earnings Per Share, Deferred Income Tax